Apollo stent for symptomatic atherosclerotic intracranial stenosis: Study results

American Journal of Neuroradiology

Volumn 28, Issue 5, 2007, Pages 830-834

  Jiang, W J ^a   Xu, X T ^a   Jin, M ^a   Du, B ^a   Dong, K H ^a   Dai, J P ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANGIOGRAPHY; ARTICLE; ATHEROSCLEROTIC INTRACRANIAL STENOSIS; BALLOON DILATATION; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; FOLLOW UP; HUMAN; MALE; OCCLUSIVE CEREBROVASCULAR DISEASE; PROSTHESIS FAILURE; STENT; TREATMENT OUTCOME;

ANGIOPLASTY, BALLOON; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTRACRANIAL ARTERIOSCLEROSIS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; STENTS; TREATMENT OUTCOME;

EID: 34248645997     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Wong KS, Li H, Lam WWM, et al. Progression of middle cerebral artery occlusive disease and its relationship with further vascular events after stroke. Stroke 2002;33:532-36
2. Prognosis of patients with symptomatic vertebral or basilar artery stenosis: the Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Study Group. Stroke 1998;29:1389-92
3. Thijs VN, Albers GW. Symptomatic intracranial atherosclerosis: outcome of patients who fail antithrombotic therapy. Neurology 2000;55:490-97
4. Kern R, Steinke W, Daffertshofer M, et al. Stroke recurrences in patients with symptomatic vs asymptomatic middle cerebral artery disease. Neurology 2005;65:859-64
5. Chimowitz MI, Lynn MJ, Howlett-Smith H, et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005;352:1305-16
6. Schumacher HC, Khaw AV, Meyers PM, et al. Intracranial revascularization therapy: angioplasty and stenting. Curr Treat Options Cardiovasc Med 2004;6:193-98
7. Hartmann M, Jansen O. Angioplasty and stenting of intracranial stenosis. Curr Opin Neurol 2005;18:39-45
8. Mori T, Kazita K, Chokyu K, et al. Short-term arteriographic and clinical outcome after cerebral angioplasty and stenting for intracranial vertebrobasilar and carotid atherosclerotic occlusive disease. AJNR Am J Neuroradiol 2000;21:249-54
9. Lylyk P, Cohen JE, Ceratto R, et al. Angioplasty and stent placement in intracranial atherosclerotic stenoses and dissections. AJNR Am J Neuroradiol 2002;23:430-36
10. Jiang WJ, Wang YJ, Du B, et al. Stenting of symptomatic M1 stenosis of middle cerebral artery: an initial experience of 40 patients. Stroke 2004;35:1375-80
11. Kim DJ, Lee BH, Kim DI, et al. Stent-assisted angioplasty of symptomatic intracranial vertebrobasilar artery stenosis: feasibility and follow-up results. AJNR Am J Neuroradiol 2005;26:1381-88
12. Du Mesnil de Rochemont R, Turowski B, Buchkremer M, et al. Recurrent symptomatic high-grade intracranial stenoses: safety and efficacy of undersized stents: initial experience. Radiology 2004;231:45-49
13. Yu W, Smith WS, Singh V, et al. Long-term outcome of endovascular stenting for symptomatic basilar artery stenosis. Neurology 2005;64:1055-57
14. Marks MP, Marcellus M, Norbash AM, et al. Outcome of angioplasty for atherosclerotic intracranial stenosis. Stroke 1999;30:1065-69
15. SSYLVIA Study Investigators. Stenting of symptomatic atherosclerotic lesions in the vertebral or intracranial arteries (SSYLVIA). Stroke 2004;35:1388-92. Epub 2004 Apr 22
16. Henkes H, Miloslavskil E, Lowens S, et al. Treatment of intracranial atherosclerotic stenoses with balloon dilatation and self-expanding stent deployment (WingSpan). Neuroradiology 2005;47:222-28
17. Coull AJ, Rothwell PM. Underestimation of the early risk of recurrent stroke: evidence of the need for a standard definition. Stroke 2004;35:1925-29
18. Morgenstern LB, Lisabeth LD, Mecozzi AC, et al. A population-based study of acute stroke and TIA diagnosis. Neurology 2004;62:895-900
19. Samuels OB, Joseph JJ, Lynn MJ, et al. A standardized method for measuring intracranial arterial stenosis. AJNR Am J Neuroradiol 2000;21:643-46
20. Tardif JC, Cote G, Lesperance J, et al. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty: Multivitamins and Probucol Study Group. N Eng J Med 1997;337:365-72
21. Rodes J, Cote G, Lesperance J, et al. Prevention of restenosis after angioplasty in small coronary arteries with probucol. Circulation 1998;97:429-36
22. Pearson TA, Blair SN, Daniels SR, et al. AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update - Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation 2002;106:388-91
23. Jiang WJ, Du B, Leung TW, et al. Symptomatic intracranial stenosis: cerebrovascular complications from elective stent placement. Radiology 2007;243:188-97
24. Kasner SE, Chimowitz MI, Lynn MJ, et al. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation 2006;113:555-63
25. Takis C, Kwan ES, Pessin MS, et al. Intracranial angioplasty: experience and complications. AJNR Am J Neuroradiol 1997;18:1661-68
26. Masuo O, Terada T, Walker G, et al. Patency of perforating arteries after stent placement? A study using an in vivo experimental atherosclerosis-induced model. AJNR Am J Neuroradiol 2005;26:543-48
27. Jiang WJ, Srivastava T, Gao F, et al. Perforator stroke after elective stenting of symptomatic intracranial stenosis. Neurology 2006;66:186-72